From candidate to default: the company has just been placed inside buyers' own purchasing systems
The model's full reasoning — Q1 2016 call → NOWe need to determine if management describes that the company has recently crossed from being a candidate to being an approved, specified, listed, qualified, registered, reimbursed, or pre-authorized choice inside buyers' own systems, so that future business can arrive without a discrete selling event, and that this status is new enough that most volume is still ahead. The transcript mentions the B-21 program award. Larry Lawson says: "In March, Spirit AeroSystems was named by the Secretary of the Air Force as one of seven subcontractors on the B-21 program, we’re very proud to be part of the team. We're currently in the early phase of the engineering and manufacturing development program, but this is a landmark win that gives us a new growth engine. It confirms our value proposition, not only in aerospace, but also in defense, as a proven, value-added, low-cost partner." This is a specific program award, not a general listing or qualification. It's a contract win, not a status that makes future orders automatic. The B-21 is a specific program, and being a subcontractor means they are on the team for that program. But does that mean they are now an approved supplier for future business? It's a specific program, not a broad access. Also, the program is in early phase, so future volume is ahead, but the access is to that specific program, not a general pathway. The question asks about being inserted into a system through which transactions routinely flow, like an approved supplier list, formulary, etc. This is a specific contract award, not a general qualification. Also, management does not describe that this status will bring business without a discrete selling event; it's a specific program they are part of. So likely NO. Another point: The company achieved investment-grade credit ratings. That is not a buyer-side system. It's a financial rating. The 737 MAX first flight is a milestone, but not a new access status. The A350 progress is about cost, not access. Thus, no mention of being placed into a buyer's purchasing system. The B-21 is a specific win, not a general listing. So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| INGN | Inogen, Inc. | Q1 2023 | 2023-05-05 | F |
| HBB | Hamilton Beach Brands Holding Company | Q3 2022 | 2022-11-05 | C |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| MGNI | Magnite, Inc. | Q1 2022 | 2022-05-04 | D |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
PRIM · Q2 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this shift for the newly acquired T&D segment: after the Willbros acquisition (closed June 1, 2018), the T&D Group gained access to major utilities that had been hesitant due to prior financial concerns. With Primoris as parent, they signed new awards from the 3 largest electrical utilities (one announced MSA, two not yet announced), allowing work to flow under existing relationships without repeated persuasion. Management explicitly ties this to the recent acquisition and notes the MSA backlog now at $1.1 billion (first time exceeding $1 billion), with one-year estimated MSA revenue at $1.1 billion and continued growth expected.
AGIO · Q3 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this transition for TIBSOVO. Steve Hoerter states that the company launched in July 2018 and is now receiving reimbursement with “no payer-related coverage issues,” with the payer mix (60% Medicare, 35% commercial) reflecting routine placement in those systems. He further notes that initial prescriptions are being written by over 100 unique prescribers and that awareness is already above 90%, confirming the product has moved from candidate status into the reimbursement and purchasing pathways. Because the launch is only a few months old at the time of the call, the $4.
AZEK · Q2 2024 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, etc...YES The transcript shows management describing recent and incremental shelf-space gains in both pro and retail channels as a new development that will support growth in 2025, with investments planned for Q4 to enable these gains. This is framed as moving beyond prior years' steady execution into fresh wins that create a tailwind for future 2025 volume, where the company is now positioned to benefit from expanded availability in buyer systems (catalogs, dealer networks, and retail displays) without needing to re-persuade for each order.